Dr. Lal PathLabs launches test for Amyloidosis disease

15 Apr 2025 Evaluate

Dr. Lal PathLabs has introduced Amyloid typing by laser capture microdissection & mass spectrometry - a revolution test for accurately identifying different types of Amyloid proteins. With this launch, the company becomes the first diagnostic chain in South Asia to offer this highly specialized test. The company has launched this test, under the guidance of National Amyloidosis Centre, London (UK). 

Amyloidosis is a disease where the abnormal or misfolded amyloid protein accumulates in various vital organs leading to loss of function or even death in some cases. More than 40 types of Amyloid proteins are discovered till date, and precise knowledge about the type of Amyloid helps doctors in choosing the correct treatment or management plan for the patient. Kidney, Heart, Lungs, Skin are the most common involved, however any organ in the body can be affected.

Dr. Lal Pathlabs is a provider of diagnostic and related healthcare tests and services in India.

Dr. Lal Pathlabs Share Price

2906.55 118.85 (4.26%)
25-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 6951.85
Max Healthcare Inst 1068.00
Narayana Hrudayalay 1787.40
Aster DM Healthcare 505.25
Global Health 1214.75
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...